Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise in taming blood cancers

NCT ID NCT04014205

First seen Jun 18, 2026 · Last updated Jun 18, 2026

Summary

This study tests a new drug called orelabrutinib for people with B-cell blood cancers (like lymphoma or leukemia). The goal is to see if the drug can shrink tumors and control the disease, while checking for side effects. About 81 adults with relapsed or hard-to-treat cancers will take the pill, and researchers will monitor how well it works and how safe it is.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Anne Arundel Medical Center (AAMC) Oncology and Hematology

    Annapolis, Maryland, 21401-3093, United States

  • Asclepes Research Centers - Weeki Wachee

    Weeki Wachee, Florida, 34607, United States

  • Carmel Medical Center

    Haifa, Israel

  • Cherkassy Regional Oncology Center

    Cherkasy, Ukraine

  • Clinical Research Alliance

    Westbury, New York, 11590, United States

  • Coborn Cancer Center

    Saint Cloud, Minnesota, 56303, United States

  • Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center)

    Topeka, Kansas, 66606, United States

  • Desert Hematology Oncology Medical Group, Inc.

    Rancho Mirage, California, 92270, United States

  • Florida Cancer Specialists (FCS) South

    Fort Myers, Florida, 33901, United States

  • Gabrail Cancer Research Center

    Canton, Ohio, 44718, United States

  • Goshen Center for Cancer Care

    Goshen, Indiana, 46526, United States

  • Guthrie Cancer Center

    Sayre, Pennsylvania, 18840, United States

  • Institute of Blood Pathology and Transfusion Medicine

    Lviv, Ukraine

  • Khmelnytskyi Regional Hospital

    Khmelnytskyi, Ukraine

  • Los Angeles Cancer Network - Good Samaritan Hospital Location

    Los Angeles, California, 90017, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Mayo Clinic - Minnesota

    Rochester, Minnesota, 55905-0001, United States

  • Mayo Clinic-Mayo Clinic Hospital-Phoenix

    Phoenix, Arizona, 85054-4502, United States

  • Medical Oncology Associates PS (dba Summit Cancer Centers)

    Spokane, Washington, 99201, United States

  • National Cancer Institute

    Kyiv, Ukraine

  • Northwest Neurology - Rolling Meadows Office

    Elk Grove Village, Illinois, 60007, United States

  • Orchard Healthcare Research Inc.

    Skokie, Illinois, 60077, United States

  • Pacific Cancer Medical Center

    Anaheim, California, 92801-1824, United States

  • Prairie Lakes Cancer Center

    Watertown, South Dakota, 57201, United States

  • Sarah Cannon Research Institute - Tennessee Oncology

    Nashville, Tennessee, 37203-1625, United States

  • Soroka Medical Center

    Beersheba, Israel

  • Southeast Nebraska Cancer Center

    Lincoln, Nebraska, 68510-2496, United States

  • St. Luke's Hospital - Medical and Diagnostic Center

    Kropyvnytskyi, Ukraine

  • Summit Medical Group

    Florham Park, New Jersey, 07932-0001, United States

  • Tennessee Cancer Specialists

    Knoxville, Tennessee, 37909-1327, United States

  • Tennessee Oncology - Chattanooga Oncology & Hematology Associates

    Chattanooga, Tennessee, 37404-1130, United States

  • The Oncology Institute of Hope & Innovation

    Whittier, California, 90603, United States

  • Transcarpathian Regional Clinical Hospital named after Andrii Novak

    Uzhhorod, Ukraine

  • Tulane University School of Medicine - Tulane Cancer Center Comprehensive Clinic TCCCC

    New Orleans, Louisiana, 70112, United States

  • University of Pittsburgh - Hillman Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

  • Uniwersyteckie Centrum Kliniczne

    Gdansk, Poland

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia B-cell neoplasm B-cell non-Hodgkin lymphoma follicular lymphoma mantle cell lymphoma marginal zone lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.